KollagenX Expands Formulations of Its 24kt Gold Product Line Through FDA Approved Samson Pharmaceuticals Laboratory in Los Angeles, California
(firmenpresse) - CHINO, CA -- (Marketwired) -- 11/03/15 -- KollagenX® Corp. (OTCQB: KGNX) -- KollagenX management has engaged Samson Pharmaceuticals to expand its 24KT Gold Skin Care Collection. KollagenX believes that Samson Pharmaceuticals is the right fit for KollagenX®; they are FDA registered and a drug licensed laboratory in the United States currently manufacturing a diverse line of products ranging from OTC, cosmetics, dietary supplements and others.
To find out more about Samson Pharmaceuticals go to:
About KollagenX®
KollagenX® is a California based cosmetic company that's main focus is nano gold technology also known as NGT®. KollagenX® was formed by Rondell Fletcher and George Huerta in early 2008. KollagenX® develops and introduces new safe, more affordable eco-friendly NTG® products that will help improve the quality of lives. The company's unique anti-aging skin care products restore a natural youthful glow and a smoother, supplier appearance. KollagenX® helps bring the nourishment your skin needs to be healthier and function more effectively.
For more information on KollagenX® Corp:
Forward-Looking Statements
Forward-Looking Statement Any statements made in this press release which are not historical facts contain certain forward-looking statements; as such term is defined in the Private Security Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company's operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward-looking statement. This press release shall not be deemed a general solicitation.
Contact:
KollagenX Corp.
(909) 465-1784
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.11.2015 - 14:00 Uhr
Sprache: Deutsch
News-ID 431486
Anzahl Zeichen: 0
contact information:
Town:
CHINO, CA
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 156 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"KollagenX Expands Formulations of Its 24kt Gold Product Line Through FDA Approved Samson Pharmaceuticals Laboratory in Los Angeles, California"
steht unter der journalistisch-redaktionellen Verantwortung von
KollagenX Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
